1.Inhibition of Cell Migration by Corticotropin-Releasing Hormone (CRH) in Human Natural Killer Cell Line, NK-92MI.
Soyoung CHEON ; Saik BANG ; Daeho CHO
Immune Network 2005;5(4):247-251
BACKGROUND: Natural killer (NK) cells are CD3 (-) CD14 (-) CD56 (+) lymphocytes. They play an important role in the body's innate immune response. They can induce spontaneous killing of cancer cells or virus-infected cells via the Fas/Fas ligand or the granzyme/perforin systems. The corticotropin-releasing hormone (CRH) is an important regulator for the body's stress response. It promotes proliferation and migration of various cancer cells through the CRH type 1 receptor under stress, and also inhibits NK or T cell activity. However, the relationship of CRH and NK cell migration to the target has not been confirmed. Herein, we study the effect of CRH on NK cell migration. METHODS: We used the human NK cell line, NK-92MI, and tested the expression of CRH receptor type 1 on NK-92MI by RT-PCR. This was to examine the effect of CRH on tumor and NK cell migration, thus NK cells (NK-92MI) were incubated with or without CRH and then each CRH treated cell's migration ability compared to that of the CRH untreated group. RESULTS: We confirmed that CRH receptor type 1 is expressed in NK-92MI. CRH can decrease NK cell migration in a time-/dose-dependent manner. CONCLUSION: These data suggest CRH can inhibit NK cell migration to target cells.
Cell Movement*
;
Corticotropin-Releasing Hormone*
;
Homicide
;
Humans*
;
Immunity, Innate
;
Killer Cells, Natural*
;
Lymphocytes
;
Receptors, Corticotropin-Releasing Hormone
2.Vitrification, in vitro fertilization, and development of Atg7 deficient mouse oocytes.
Soyoung BANG ; Geun Kyung LEE ; Hyejin SHIN ; Chang Suk SUH ; Hyunjung Jade LIM
Clinical and Experimental Reproductive Medicine 2016;43(1):9-14
OBJECTIVE: Autophagy contributes to the clearance and recycling of macromolecules and organelles in response to stress. We previously reported that vitrified mouse oocytes show acute increases in autophagy during warming. Herein, we investigate the potential role of Atg7 in oocyte vitrification by using an oocyte-specific deletion model of the Atg7 gene, a crucial upstream gene in the autophagic pathway. METHODS: Oocyte-specific Atg7 deficient mice were generated by crossing Atg7 floxed mice and Zp3-Cre transgenic mice. The oocytes were vitrified-warmed and then subjected to in vitro fertilization and development. The rates of survival, fertilization, and development were assessed in the Atg7 deficient oocytes in comparison with the wildtype oocytes. Light chain 3 (LC3) immunofluorescence staining was performed to determine whether this method effectively evaluates the autophagy status of oocytes. RESULTS: The survival rate of vitrified-warmed Atg7(f/f);Zp3-Cre (Atg7(d/d)) metaphase II (MII) oocytes was not significantly different from that of the wildtype (Atg7(f/f)) oocytes. Fertilization and development in the Atg7(d/d) oocytes were significantly lower than the Atg7(f/f) oocytes, comparable to the Atg5d/d oocytes previously described. Notably, the developmental rate improved slightly in vitrified-warmed Atg7(d/d) MII oocytes when compared to fresh Atg7(d/d) oocytes. LC3 immunofluorescence staining showed that this method can be reliably used to assess autophagic activation in oocytes. CONCLUSION: We confirmed that the LC3-positive signal is nearly absent in Atg7(d/d) oocytes. While autophagy is induced during the warming process after vitrification of MII oocytes, the Atg7 gene is not essential for survival of vitrified-warmed oocytes. Thus, induction of autophagy during warming of vitrified MII oocytes seems to be a natural response to manage cold or other cellular stresses.
Animals
;
Autophagy
;
Fertilization
;
Fertilization in Vitro*
;
Fluorescent Antibody Technique
;
Genes, vif
;
Metaphase
;
Mice*
;
Mice, Transgenic
;
Oocytes*
;
Organelles
;
Recycling
;
Survival Rate
;
Vitrification*
3.Guidewire Impaction in the Main Pancreatic Duct in a Patient with Chronic Pancreatitis:A Case Report
Soyoung KIM ; Hoonsub SO ; Seok Won JUNG ; Sung Jo BANG
The Korean Journal of Gastroenterology 2023;81(1):36-39
The guidewire is an essential accessory in ERCP. Although rare, guidewires can cause complications, such as subcapsular hepatic hematoma, perforation, knotting, fracture, and impaction, during ERCP. This report describes a guidewire impaction during the endoscopic treatment of a patient with symptomatic chronic pancreatitis. The methods used to treat guidewire impaction are not well known. In the present case, the impacted guidewire was retrieved by inserting another guidewire and dilating the space adjacent to it. Endoscopists should check for the free movement of the guidewire before stent deployment. Additionally, it is important to ask for help from experienced senior staff to overcome any challenges during the procedure. In conclusion, endoscopists should be aware of the possibility of a guidewire impaction during ERCP.
4.Prediction for TNF Inhibitor Users in RA Patients According to Reimbursement Criteria Based on DAS28.
Soyoung WON ; Yoon Kyoung SUNG ; Soo Kyung CHO ; Chan Bum CHOI ; Eun Mi KOH ; Seong Kyu KIM ; Jinseok KIM ; Tae Hwan KIM ; Hyoun Ah KIM ; Seong Su NAH ; So Young BANG ; Chang Hee SUH ; Seung Cheol SHIM ; Dae Hyun YOO ; Bo Young YOON ; Sang Hoon LEE ; Sung Won LEE ; Shin Seok LEE ; Yeon Ah LEE ; Jaejoon LEE ; Jisoo LEE ; Hye Soon LEE ; Mi Kyoung LIM ; Jae Bum JUN ; Chan Hong JEON ; Young Ok JUNG ; Won Tae CHUNG ; Hoon Suk CHA ; Jung Yoon CHOE ; Seung Jae HONG ; Sang Cheol BAE
Journal of Rheumatic Diseases 2014;21(2):64-73
OBJECTIVE: The purpose of this study is to examine the difference between the numbers of patients in rheumatoid arthritis (RA) who are eligible to TNF inhibitors by the past Korean National Health Insurance reimbursement guideline and by the disease activity score with 28-joint assessment (DAS28) based criteria. METHODS: Data were obtained from a multi-center registry for biologics users in Korean RA patients, BIOlogics Pharmacoepidemiologic StudY (BIOPSY). DAS28 was calculated based on either ESR or CRP, and DAS28 of more than 5.1 or between 3.2 and 5.1 with radiographic changes was defined as a cut-off point for the initiation of TNF inhibitors. For the maintenance criteria, we used both of improving in DAS28 score (>1.2) and low disease activity (DAS 28<3.2). Differences between the numbers in each step by two criteria were described with Chi-square test and Kappa agreement. RESULTS: Of the 489 patients in BIOPSY, 299 were included in this study. Among them, 278 patients (93.0%) were eligible of TNF inhibitors when we applied the new initiation criteria with DAS28-ESR, and 244 patients (81.6%) were indicated for TNF inhibitors with DAS28-CRP. For the maintenance criteria, a low disease activity (DAS28<3.2) in 3 months after starting TNF inhibitors is too strict for achieving (33.6% with DAS28-ESR and 50.0% with DAS28-CRP). Instead, decreasing DAS28 by more than 1.2 is more reasonable as a tool for deciding early responsiveness of TNF inhibitors in RA patients (81.2% both with DAS28-ESR and DAS28-CRP). CONCLUSION: Our results show that the candidates for TNF inhibitors will be enormously changed according to a change in the reimbursement criteria. To define appropriate patients to receive TNF inhibitors, a further study with regard to the impact of changes in the reimbursement criteria on the outcomes of RA patients will be required.
Arthritis, Rheumatoid
;
Biological Products
;
Biopsy
;
Humans
;
National Health Programs
5.Impact of early diagnosis on functional disability in rheumatoid arthritis.
Dam KIM ; Chan Bum CHOI ; Jiyoung LEE ; Soo Kyung CHO ; Soyoung WON ; So Young BANG ; Hoon Suk CHA ; Jung Yoon CHOE ; Won Tae CHUNG ; Seung Jae HONG ; Jae Bum JUN ; Young Ok JUNG ; Jinseok KIM ; Seong Kyu KIM ; Tae Hwan KIM ; Tae Jong KIM ; Eunmi KOH ; Hye Soon LEE ; Jaejoon LEE ; Jisoo LEE ; Sang Heon LEE ; Shin Seok LEE ; Sung Won LEE ; Seung Cheol SHIM ; Dae Hyun YOO ; Bo Young YOON ; Yoon Kyoung SUNG ; Sang Cheol BAE
The Korean Journal of Internal Medicine 2017;32(4):738-746
BACKGROUND/AIMS: To determine whether early diagnosis is beneficial for functional status of various disease durations in rheumatoid arthritis (RA) patients. METHODS: A total of 4,540 RA patients were enrolled as part of the Korean Observational Study Network for Arthritis (KORONA). We defined early diagnosis as a lag time between symptom onset and RA diagnosis of ≤ 12 months, whereas patients with a longer lag time comprised the delayed diagnosis group. Demographic characteristics and outcomes were compared between early and delayed diagnosis groups. Logistic regression analyses were performed to identify the impact of early diagnosis on the development of functional disability in RA patients. RESULTS: A total of 2,597 patients (57.2%) were included in the early diagnosis group. The average Health Assessment Questionnaire-Disability Index (HAQ-DI) score was higher in the delayed diagnosis group (0.64 ± 0.63 vs. 0.70 ± 0.66, p < 0.01), and the proportion of patients with no functional disability (HAQ = 0) was higher in the early diagnosis group (22.9% vs. 20.0%, p = 0.02). In multivariable analyses, early diagnosis was independently associated with no functional disability (odds ratio [OR], 1.19; 95% confidence interval [CI], 1.01 to 1.40). In a subgroup analysis according to disease duration, early diagnosis was associated with no functional disability in patients with disease duration < 5 years (OR, 1.37; 95% CI, 1.09 to 1.72) but not in patients with longer disease duration (for 5 to 10 years: OR, 1.07; 95% CI, 0.75 to 1.52; for ≥ 10 years: OR, 0.92; 95% CI, 0.65 to 1.28). CONCLUSIONS: Early diagnosis is associated with no functional disability, especially in patients with shorter disease duration.
Arthritis
;
Arthritis, Rheumatoid*
;
Delayed Diagnosis
;
Diagnosis
;
Early Diagnosis*
;
Humans
;
Logistic Models
;
Observational Study